Physician
Northwest Florida Healthcare, INC
Northwest Florida Healthcare, INC was paid $12.92M by Medicaid between Jan 2018 and Dec 2024, across 173 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 17% of everything it billed.
33Billing provider infoNORTHWEST FLORIDA HEALTHCARE, INC
CHIPLEY, FL 32428
CHIPLEY, FL 32428
33aNPI1336163708assigned 07/27/2006
33bProvider typeGeneral Practice Physician
28Total paid$12.92M
24GClaims453,034
24DCodes billed173
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in Florida
Rank by total paid#3 of 420
Median peer was paid$23K
This provider vs. median573×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,493 | $341K | |
| 2019 | 48,483 | $1.34M | |
| 2020 | 58,248 | $1.78M | |
| 2021 | 92,978 | $2.59M | |
| 2022 | 88,490 | $3.11M | |
| 2023 | 86,069 | $2.46M | |
| 2024incomplete | 65,273 | $1.30M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 17% | 2,165 | 1,697 | $2.19M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 30,816 | 21,146 | $2.05M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 28,990 | 17,084 | $1.45M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.7% | 48,862 | 29,683 | $870K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.6% | 27,957 | 17,997 | $723K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.1% | 22,450 | 9,438 | $664K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4.1% | 7,152 | 1,426 | $529K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.0% | 7,191 | 4,420 | $513K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.6% | 1,691 | 1,417 | $336K |
| 36415 | Collection of venous blood by venipuncture | 2.0% | 14,455 | 9,148 | $260K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 934 | 791 | $198K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 4,269 | 804 | $194K |
161 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 5,302 | $170K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.3% | 1,882 | $168K |
| 80053 | Comprehensive metabolic panel | 1.2% | 16,213 | $154K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 1.1% | 9,155 | $140K |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 652 | $125K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 17,782 | $98K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 445 | $90K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,680 | $88K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,361 | $85K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,858 | $83K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 445 | $82K |
| 87400 | <1% | 11,671 | $70K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,616 | $68K |
| D0272 | Bitewings - two radiographic images | <1% | 308 | $65K |
| G0378 | Hospital observation service, per hour | <1% | 1,109 | $63K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,515 | $60K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 487 | $56K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 509 | $53K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 829 | $52K |
| 82550 | <1% | 5,310 | $52K | |
| 82553 | <1% | 5,217 | $47K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,108 | $47K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 950 | $46K |
| 84484 | <1% | 5,231 | $46K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,053 | $45K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,972 | $45K |
| 97161 | <1% | 252 | $45K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 6,248 | $42K |
| 84703 | <1% | 2,430 | $37K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,772 | $37K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,176 | $36K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,842 | $34K |
| 85610 | <1% | 1,890 | $32K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 3,133 | $30K |
| 83519 | <1% | 2,951 | $30K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 508 | $28K |
| 81001 | <1% | 4,919 | $26K | |
| 85730 | <1% | 1,511 | $26K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 23 | $25K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,159 | $24K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,327 | $24K |
| 81003 | <1% | 3,264 | $21K | |
| 82150 | <1% | 1,921 | $21K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,356 | $20K |
| H1000 | Prenatal care, at-risk assessment | <1% | 690 | $19K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,284 | $19K |
| 87802 | <1% | 4,245 | $17K | |
| 83690 | <1% | 2,706 | $17K | |
| 73564 | <1% | 266 | $15K | |
| 80306 | <1% | 2,481 | $15K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 277 | $13K |
| 73630 | <1% | 304 | $12K | |
| 94760 | <1% | 872 | $11K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 76 | $11K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 772 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,692 | $10K |
| 87070 | <1% | 1,400 | $10K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,397 | $10K |
| 94664 | <1% | 816 | $9K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,605 | $8K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 36 | $8K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,185 | $7K |
| 80061 | Lipid panel | <1% | 2,203 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 505 | $6K |
| 73610 | <1% | 149 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,230 | $5K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 109 | $4K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 36 | $4K |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 113 | $4K |
| 73030 | <1% | 95 | $4K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,635 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 202 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,763 | $3K |
| 83605 | <1% | 199 | $3K | |
| 73130 | <1% | 42 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 885 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $2K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 22 | $2K |
| 97802 | <1% | 73 | $2K | |
| 0011A | <1% | 51 | $2K | |
| 87040 | <1% | 231 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 39 | $2K |
| 82607 | <1% | 725 | $2K | |
| 83735 | <1% | 527 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 36 | $1K |
| 00320 | <1% | 14 | $1K | |
| 0012A | <1% | 42 | $1K | |
| 87420 | <1% | 509 | $1K | |
| 73110 | <1% | 44 | $1K | |
| 86677 | <1% | 121 | $1K | |
| 87077 | <1% | 1,029 | $909.89 | |
| 99381 | <1% | 40 | $791.35 | |
| 87490 | <1% | 222 | $763.57 | |
| 87186 | <1% | 721 | $682.14 | |
| 99383 | <1% | 43 | $644.21 | |
| 99188 | <1% | 64 | $641.65 | |
| 72100 | <1% | 18 | $547.02 | |
| 90670 | <1% | 750 | $540.88 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 405 | $505.00 |
| 99490 | Ccm add 20min | <1% | 157 | $475.70 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 64 | $472.08 |
| 36600 | <1% | 20 | $379.63 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 156 | $355.00 |
| 99442 | <1% | 37 | $312.21 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,917 | $309.90 |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 26 | $300.36 |
| 20610 | <1% | 531 | $172.43 | |
| 84439 | <1% | 518 | $148.21 | |
| 90671 | <1% | 446 | $147.52 | |
| 82728 | <1% | 79 | $145.05 | |
| 80305 | <1% | 17 | $126.42 | |
| 90461 | <1% | 369 | $120.00 | |
| 84436 | <1% | 268 | $98.33 | |
| 99406 | <1% | 15 | $95.16 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 65 | $93.70 |
| 90686 | <1% | 252 | $81.26 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 225 | $30.24 |
| 83540 | <1% | 92 | $27.02 | |
| 82746 | <1% | 82 | $17.43 | |
| 84479 | <1% | 151 | $12.66 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 203 | $12.00 |
| 87590 | <1% | 222 | $11.32 | |
| 0013A | <1% | 22 | $8.73 | |
| 99173 | <1% | 517 | $5.97 | |
| 85027 | <1% | 166 | $2.04 | |
| 90672 | <1% | 71 | $0.04 | |
| 3078F | <1% | 7,621 | $0.03 | |
| 1159F | <1% | 5,167 | $0.01 | |
| 90723 | <1% | 274 | $0.01 | |
| 3074F | <1% | 8,050 | $0.01 | |
| 3008F | <1% | 12,343 | $0.01 | |
| 1126F | <1% | 3,567 | $0.01 | |
| 1160F | 0% | 5,699 | $0.00 | |
| 90633 | 0% | 253 | $0.00 | |
| 3077F | 0% | 101 | $0.00 | |
| 90710 | 0% | 368 | $0.00 | |
| 3725F | 0% | 185 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 105 | $0.00 |
| 3046F | 0% | 185 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 155 | $0.00 |
| 90648 | 0% | 326 | $0.00 | |
| 80076 | 0% | 20 | $0.00 | |
| 90715 | 0% | 14 | $0.00 | |
| 85378 | 0% | 13 | $0.00 | |
| 1036F | 0% | 5,435 | $0.00 | |
| 1125F | 0% | 941 | $0.00 | |
| 1034F | 0% | 567 | $0.00 | |
| 3079F | 0% | 982 | $0.00 | |
| 92551 | 0% | 501 | $0.00 | |
| 3044F | 0% | 105 | $0.00 | |
| 90651 | 0% | 53 | $0.00 | |
| 90680 | 0% | 334 | $0.00 | |
| 99000 | 0% | 122 | $0.00 | |
| 90698 | 0% | 155 | $0.00 | |
| 90697 | 0% | 124 | $0.00 | |
| 3075F | 0% | 113 | $0.00 | |
| 96127 | 0% | 16 | $0.00 | |
| 90696 | 0% | 52 | $0.00 | |
| D2335 | 0% | 47 | $0.00 | |
| 3080F | 0% | 42 | $0.00 | |
| 90677 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLISENBY, STEVEN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Northwest Florida Healthcare, INC. | Vernon, FL | $19K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.